| 000 | 00987nam a22001457a 4500 | ||
|---|---|---|---|
| 005 | 20230317112805.0 | ||
| 008 | 230317b ph ||||| |||| 00| 0 eng d | ||
| 040 | _cOCT | ||
| 240 |
_aJournal of psychosocial nursing and mental health services / _hNovember 2022 |
||
| 245 |
_aDectromethorphan : _bfrom cough suppressant to antidepressant |
||
| 260 |
_aThorofarem Jersey : _bSlack Incorporated, _c2022 |
||
| 300 | _aVol. 60 (11) : pages 9-11 | ||
| 500 | _aDextromethorphan (DXM) has been repurposed several times over the past 7 decades: first as a cough suppressant, then as a compounded formulation with quinidine for treatment of pseudobulbar affect, and most recently as a compounded formulation with bupropion for treatment of major depressive disorder. The current article describes the history and purported mechanisms of action of DXM for each use and the uniquely rapid action and safety profile of the oral dextromethorphanbupropion antidepressant formulation. | ||
| 942 |
_2ddc _cCR _n0 |
||
| 999 |
_c8579 _d8579 |
||